IC
PMC

Intersect Capital’s PharMerica Corporation PMC Stock Holding History

Intersect Capital’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2
Closed – – 427
2015
Q1 		$0 Buy
+2
New +$50 ﹤0.01% 506

Other funds holding PMC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CCM
Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Intersect Capital's PMC Position: Q2 2015 in Review

Intersect Capital sold out of PharMerica Corporation (PMC) in Q2 2015, closing a stake of 2 shares.

Intersect Capital first reported a position in PMC in Q1 2015 and held it in 1 quarter. The position peaked at $0 in Q1 2015. 172 funds tracked by Wall St. Rank hold PMC as of Q2 2015.

  • Intersect Capital reported no remaining PharMerica Corporation position as of Q2 2015 after selling out during the quarter.
  • Intersect Capital sold 2 PharMerica Corporation shares in Q2 2015.
  • Intersect Capital first reported a position in PharMerica Corporation in Q1 2015 and held it in 1 quarter.
  • Intersect Capital's PharMerica Corporation position peaked at $0 in Q1 2015.
  • 172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.